Indication
Schnitzler syndrome
2 clinical trials
3 products
Product
dapansutrileClinical trial
A Pilot, Open-Label, Phase 2, Single-Center, Repeat Dose, Proof- Of-Concept Safety, Pharmacodynamics and Efficacy Study of Orally Administered Dapansutrile Capsules in Subjects With Schnitzler's SyndromeStatus: Terminated, Estimated PCD: 2018-05-29
Product
RPH-104Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler SyndromeStatus: Not yet recruiting, Estimated PCD: 2023-08-01
Product
Placebo